Subcutaneous Epcoritamab Versus Standard of Care in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Phase 3 EPCORE DLBCL-1 Trial Article

Web of Science: 000866743000053

Cited authors

  • Fox CP, Roost CM, Pieternella L, Balari AS, Zinzani PL, Jun W, Laura F, Vindelov SD, Catherine T


Publication date

  • 2022

Published in

International Standard Serial Number (ISSN)

  • 0361-8609

Number of pages

  • 2

Start page

  • S32

End page

  • S33


  • 97